Personnel Information

写真a

Yokota Takanori


Job title

Professor

Mail Address

The inquiry by e-mail is 《here

Graduating School 【 display / non-display

  • Tokyo Medical and Dental University, Faculty of Medicine, 1984, Graduated

Degree 【 display / non-display

  • Medical Doctor, Tokyo Medical and Dental University

Campus Career 【 display / non-display

  • 2014.08
    -
    2018.03
    Tokyo Medical and Dental University, Graduate School of Medical and Dental Sciences, Medical and Dental Sciences, Cognitive and Behavioral Medicine, Neurology and Neurological Science, Professor
  • 2018.04
    -
    2020.05
    Tokyo Medical and Dental University, Graduate School of Medical and Dental Sciences, Medical and Dental Sciences, Cognitive and Behavioral Medicine, Neurology and Neurological Science, Professor
  • 2020.06
    -
    Now
    Tokyo Medical and Dental University, Graduate School of Medical and Dental Sciences, Medical and Dental Sciences, Cognitive and Behavioral Medicine, Neurology and Neurological Science, Professor

Research Areas 【 display / non-display

  • Neurology

 

Published Papers & Misc 【 display / non-display

  • Asada K, Sakaue F, Nagata T, Zhang JC, Yoshida-Tanaka K, Abe A, Nawa M, Nishina K, Yokota T. Short DNA/RNA heteroduplex oligonucleotide interacting proteins are key regulators of target gene silencing. Nucleic acids research. 2021.04; ( PubMed, DOI )

  • Noda K,Yagi Y,Yokota T. Evaluation of the risk factors predicting thrombotic complications associated with intravenous immunoglobulin therapy in neuroimmunological diseases Neurological Sciences. 2021.04; ( DOI )

  • Ono D, Asada K, Yui D, Sakaue F, Yoshioka K, Nagata T, Yokota T. Separation-related rapid nuclear transport of DNA/RNA heteroduplex oligonucleotide: unveiling distinctive intracellular trafficking. Molecular therapy. Nucleic acids. 2021.03; 23 1360-1370. ( PubMed, DOI )

  • Yokote H, Toru S, Nishida Y, Hattori T, Sanjo N, Yokota T. Serum amyloid A level correlates with T2 lesion volume and cortical volume in patients with multiple sclerosis. Journal of neuroimmunology. 2021.02; 351 577466. ( PubMed, DOI )

  • Asami Y, Nagata T, Yoshioka K, Kunieda T, Yoshida-Tanaka K, Bennett CF, Seth PP, Yokota T. Efficient Gene Suppression by DNA/DNA Double-Stranded Oligonucleotide In Vivo. Molecular therapy : the journal of the American Society of Gene Therapy. 2021.02; 29 (2): 838-847. ( PubMed, DOI )

display all >>

Books etc 【 display / non-display

  • Sekiguchi T, Abe K, Ohkubo T, Kanouchi T, Yokota T. Annual Review Neurology 2014. Chugai-igaku-sha Co.,Ltd, 2014.01 Pathomechanisms of the onset and progression of amyotrophic lateral sclerosis (ALS) (ISBN : 978-4-498-22814-6)

Conference Activities & Talks 【 display / non-display

  • 陳 清夢、服部 高明、喜納 里子、平田 浩聖、大原 正裕、森藤 弘士、横田 隆徳. 回転歩行と多重課題を用いた多発性硬化症患者の歩行障害の研究. 第62回日本神経学会学術大会 2021.05.22 京都

  • Chunyan Jia,Kotaro Yoshioka,Su Su Lei Mon,Maho Katsuyama,Kie Tanaka-yoshida,Tetsuya Nagata,Takanori Yokota. Hetereoduplex oligonucleotiede mitigates various types of acute CNS toxicities via CSF route. 第62回日本神経学会学術大会 2021.05.21 京都

  • Yurie Nose,Ikuko Uwano,Ukihide Tateishi,Makoto Sasaki,Takanori Yokota,Nobuo Sanjo. Clinical and radiological efficacy of deferiprone in post-operative superficial siderosis. 第62回日本神経学会学術大会 2021.05.20 京都

  • Taiki Matsubayashi,Takaaki Hattori,Masahiro Ohara,Kosei Hirata,Qingmeng Chen,Sato ko Kina,Koji Morito,Kaoru Shimano,Takanori Yokota. Dopaminergic denervation in executive striatum predicts response to L-dopa in Parkinson's disease. 第62回日本神経学会学術大会 2021.05.20 京都

  • Masahiro Ohara,Takaaki Hattori,Taiki Matsubayashi,Kosei Hirata,Qingmeng Chen,Satoko Kina,Koji Morito,Kaoru Shimano,Takanori Yokota. Inter-regional balance within striatum affects cognition and dual-task gait in Parkinson's disease. 第62回日本神経学会学術大会 2021.05.20 京都

display all >>

Patents 【 display / non-display

  • CHIMERIC DOUBLE-STRANDED NUCLEIC ACID

    Patent Number: 10329567

  • CHIMERIC DOUBLE-STRANDED NUCLEIC ACID

    Patent Number: 10337006

  • CHIMERIC SINGLE-STRANDED ANTISENSE POLYNUCLEOTIDES AND DOUBLE-STRANDED ANTISENSE AGENT

    Patent Number: 10844374

  • CHIMERIC SINGLE-STRANDED ANTISENSE POLYNUCLEOTIDES AND DOUBLE-STRANDED ANTISENSE AGENT

    Patent Number: 2961841

  • CARRIER FOR USE IN DELIVERING DRUG, CONJUGATE, COMPOSITION COMPRISING SAME, AND METHOD FOR ADMINISTRATING SAME

    Patent Number: 9,937,263

display all >>

Others 【 display / non-display

  • 2018.06

    Journal of Controlled Release